pound into oestrogen by a microsomal preparation from human term placenta more radioactivity was liberated in formic acid (61.6%) than in water (38.4%).
In a parallel experiment with the (19-S)-19-3H-labelled compound the order of radioactivity was reversed: formic acid (23.4%), water (76.2%). 4. These observations are interpreted in terms of the removal of the 19-S-hydrogen atom in the conversion of a 19-hydroxy androgen into a 19-oxo androgen during oestrogen biosynthesis. 5. It is suggested that the removal of C-19 in oestrogen biosynthesis occurs compulsorily at the oxidation state of a 19-aldehyde with the liberation of formic acid.
One of the processes involved in the biosynthesis of an oestrogen from an androgen of the type (I) is the removal of the 19-methyl group. Studies directed towards an understanding of the mechanism of elimination of C-19 have shown that under the conditions of oestrogen biosynthesis both 19-hydroxyandrostenedione (II) (Meyer, 1955; Ryan, 1959; Hayano, Longchampt, Kelly, Gual & Dorfman, 1960; Longchampt, Gual, Ehrenstein & Dorfman, 1960; Breuer & Grill, 1961; Morato, Hayano, Dorfman & Axelrod, 1961; Axelrod & Goldzeiher, 1962; Wilcox & Engels, 1965) and 19-oxoandrostenedione (IV) (Akhtar & Skinner, 1968) are formed. The efficient conversion of compounds (II) and (IV) into oestrone (V) is also well documented (Akhtar & Skinner, 1968) . These observations are interpreted in terms of a sequence of reactions of the type outlined in Scheme 1 for the 
Scheme 1. Reactions 1 and 2 refer to the conversion, in two steps, of the 3,B-hydroxy-5-ene system into the 3-oxo-4-ene system. HA represents the 19-R-hydrogen atom; HB represents the 19-S-hydrogen atom.
removal of C-19 in oestrogen biosynthesis. The requirement for NADPH and oxygen in the formation of the 19-oxo compound (IV) from the corresponding hydroxy compound (II) (Akhtar & Skinner, 1968 ) is particularly noteworthy and this has been attributed to the involvement of a dihydroxy intermediate of the type (III). Work on reactions at 'non-activated' carbon atoms has made available a number of compounds (Akhtar & Barton, 1962; Akhtar & Barton, 1964; Kalvoda, Huesler, Ueberwasser, Anner & Wettstein, 1963) required for the stereospecific introduction of a tritium label at C-19 in 19-hydroxy androgens. We have now synthesized these compounds and have used them for studying the enzymic mechanisms of some of the reactions of Scheme 1. To highlight the oxidation and stereochemical status of C-19 a non-systematic steroid nomenclature is used in this paper.
RESULTS AND DISCUSSION Synthe8i8 of (19-R)-19-3H-labelled and (19-S)-19-3H-labelledd-19-hydroxy androgen8. The two hydrogen atoms at C-19 in 19-hydroxyandrost-5-ene-3,B,17,B-diol (structure of type VIJa and VIIIa, Scheme 2) are chemically equivalent and therefore the introduction of a label stereospecifically into either one of them should offer a special challenge. We have, however, taken advantage of the observation of Caspi & Wicha (1966) , who showed that the reaction of methyl-lithium with the 19-aldehyde group in the compound (VIb) gave predominantly a single alcohol for which the structure (IX) was proposed. The formation of the alcohol with the stereochemistry shown in (IX) may be rationalized if it is assumed that the methyl carbanion generated from methyl-lithium attacks the carbonyl group from the ac-side of the steroid molecule, the carbonyl (VI') group existing predominantly in the form (VI) rather than the alternative extreme form (VI'). If the stereoelectronic factors responsible for directing the attack of methyl-lithium on the aldehyde (VIb) are maintained in the reaction of the same compound (VIb) or a similar compound (VIa) with tritiated sodium borohydride, then the resulting primary alcohol should contain the tritium atom predominantly in the R-configuration, as shown in the structure (VIIa and VIIb) in Scheme 2. The aldehyde (VIa) containing hydroxyl groups at positions 3, and 17, was reduced with tritiated sodium borohydride to furnish the radioactive triol (VIIa); the latter compound, as noted below, contained radioactivity associated predominantly with one of the two C-19 hydrogen atoms. By analogy with the reaction of methyl-lithium on the aldehyde (VIb) we tentatively formulate the compound obtained from the reaction of tritiated sodium borohydride with the aldehyde (VIa) as being predominantly l9-hydroxy[(19-R)-19-3H]-androst-5-ene-3fl,17fi-diol (VIIa) . Similarly the reaction of the aldehyde (VIb), which contained a 3ft,17fi-diacetoxy function, with tritiated sodium borohydride gave the compound (VIIb), which was hydrolysed with methanolic potassium hydroxide to the triol (VIIa). The enzymic experiments described in the next section will show that the steric distribution of tritium in the triol (VIIa) produced by the latter method was almost identical with that obtained in the triol (VIIa) produced by the direct reduction of compound (VIa) with tritiated sodium borohydride. This suggests that the nature of the 3f,-substituent does not influence the steric course of the reduction. The configuration assigned to the alcohol (IX) by Caspi & Wicha (1966) and, by implication, to the compound (VIIa) in the present work would require that, of the two orientations (VI) and (VI') for the aldehyde group, the arrangement (VI) is favoured. The explanation that the observed stereospecificity is due to hydrogen-bonding between the 3,-hydroxy group and the 19-carbonyl group (X), favouring the conformation (VI), may be rejected since the change from a 3#-hydroxyl group to a 39-acetoxyl group exercised no influence on the steric course of reduction. It is therefore suggested that the conformation (VI) may be favoured because of the superior overlap of the iT orbitals that may be achieved in the former case owing to the transoid arrangement of the 5,6-double bond and the carbonyl group. The participation of the 5,6-double bond on the photochemical reactivity of the 19-aldehyde group has previously been observed (Akhtar, 1965) . The present work suggests that the 5,6-double bond may also influence the ground-state conformation of the aldehyde group in the compounds (VIa) and (VIb). When the diacetoxy alcohol (VIIb) was oxidized with chromium trioxide in pyridine the radioactive aldehyde (19-tritiated VIb) was obtained in good yield. The latter was then hydrolysed with methanolic 5% potassium hydroxide to the compound (19-tritiated VIa), which on reduction with sodium borohydride furnished the triol (VIIIa). This contained radioactivity associated predominantly with the opposite hydrogen to the compound (VIIa) and therefore may be tentatively formulated
Biological conversion of the 3,B-hydroxy-5-ene 8y8tem into a 3-oxo-4-ene 8y8tem. The two crucial compounds (VIIa) and (VIIIa) having been made available, we were in a position to study the absolute stereochemistry of hydrogen elimination in the conversion of the 19-hydroxy androgen (II) into the corresponding 19-oxo compound by human termplacental microsomal preparation.
To appreciate the main theme developed below it is, however, necessary to include some supplementary comments. It is to be noted that the microsomal preparation used in the present work for oestrogen biosynthesis includes an additional enzyme system that converts 3fl-hydroxy-5-ene compounds into the corresponding 3-oxo-4-ene compounds (reactions 1 and 2, Scheme 1). Another feature requiring comment is the fact that whether the precursors of oestrogen contain a 17-oxo or a 17,B-hydroxy group it seems from our work that the predominant product is the 17-oxo-group-containing oestrone (V). This observation suggests that during oestrogen biosynthesis with the placental microsomal preparation the 17fl-hydroxy group is readily oxidized to a carbonyl group. The oxidationisomerization sequence represented by reaction 1 and reaction 2 in Scheme 1 is particularly advantageous since it allows a convenient generation in 8itU of the (19-R)-19-3H-labelled and (19-S)-19-3H-labelled compounds of structure (II) from the corresponding compounds (VIIa) and (VIIIa); such a conversion would be cumbersome if it had to be performed chemically.
Biological converi-on of the (19-R)-19-3H-labelled and (19-S)-19-3H-labelled 19-hydroxy compound8 into oe8trone. The sequence proposed in Scheme 1 would require that in the conversion of the alcohol (II) into oestrone (V) one of the two hydrogen atoms at C-19 of(II) will be liberated as a proton (II -> III, (VIIa) or from the (19-S)-19-3H-labelled compound (VIIIa) will contain radioactivity distributed equally between its two hydrogen atoms. The further oxidation of formaldehyde must therefore give the same distribution of radioactivity in formic acid and water whether the precursor was compound (VIIa) or compound (VIIIa).
In conclusion, the current status of oestrogen biosynthesis may be summarized as follows. The conversion of an androgen of the type (I) into oestrone involves at least two successive hydroxylations. The first hydroxylation results in the formation of a 19-hydroxy compound of the type (II) and the second hydroxylation gives a 19-oxo compound of the type (IV). The latter is probably formed through the intermediacy of a diol of the type (III). In the conversion of the 19-hydroxy compound (II) into the 19-oxo compound (IV) it is the 19-S-hydrogen atom that is removed. It is emphasized that the removal of C-19 in oestrogen biosynthesis must occur at the oxidation level of an aldehyde, thus liberating formic acid. The reactions occurring in ring A in the further conversion of the aldehyde (IV) into oestrone (V) are less well understood. Indirect evidence, however, suggests that another hydroxylated intermediate may intervene between compounds (IV) and (V) (Townsley & Brodie, 1968; Akhtar & Skinner, 1968) .
EXPERIMENTAL
Infrared spectra were determined on a Unicam SP. 200 spectrometer and ultraviolet spectra on a Unicam SP. 800 spectrometer. Melting points were determined on a Gallenkamp Melting Point Apparatus and are uncorrected. All the compounds described below gave the expected i.r. and u.v. spectra. For preparative (2mm.) and analytical (0.4mm.) t.l.c. silica gel preparations HF254 and GF254 respectively (E. Merck A.-G., Darmstadt, Germany) were used. All radioactivity measurements were taken on a Beckman Liquid Scintillation System, model CPM 200, with Butyl-PBD [2-(4-tert.-butylpheny)-5-(4-biphenylyl)-1 oxa-3,4-diazole] from CIBA (A.R.L.) Ltd., Duxford, Cambs., as scintillant in toluene (8g./l.) with up to 50% (vfv) of methanol for counting aqueous solutions. All samples were corrected for quenching with respect to a standard sample of [19-3H]cholest-5-en-3,B-ol acetate, either by external or by internal standardization. The counting efficiency was about 40-50%. NADP+ (disodium salt), NAD+ and glucose 6-phosphate dehydrogenase were supplied by C. F. Boehringer und Soehne G.m.b.H., Mannheim, Germany. Dehydroepiandrosterone acetate (androst-5-en-3/3-ol-17-one acetate) was supplied by Henly and Co., New York, N.Y., U.S.A. All other chemicals (Reagent and Biochemical Grades) were obtained from BDH Chemicals Ltd., Poole, Dorset. Preparation of human term.placental microsomes and incubation procedure. Human term placentae were cooled to 00 within 5 min. of delivery and dissected and homogenized within 45min. of delivery. Microsomal preparations were made as described by Ryan (1959) and stored at -°16 as portions equivalent to approx. 30g. wet wt. of tissue in 2-5ml. of 0-05M-sodium phosphate buffer, pH7d1. Each incubation mixture contained 2-5ml. of 0-05m-sodium phosphate buffer, pH 7-1, 0-66,.umole of steroid substrate dissolved in 0-ml. of methanol, 5-2,umoles of NADP+, 0-5unit of glucose 6-phosphate dehydrogenase, 26,umoles ofglucose 6-phosphate and 2-5ml. ofthe microsomal suspension in buffer, and was incubated at 370 for up to 2hr.
Incubations were terminated and the steroids extracted as described by Wilcox & Engels (1965) and separated by t.l.c. as described by Akhtar & Skinner (1968) .
Analy8is of formate, formaldehyde and water from incubations of 19-3H-labelled 19-oxygenated androgene. The incubations were terminated by adding formaldehyde (39mg.), formic acid (72mg.) and 0-5ml. of orthophosphoric acid (sp.gr. 1-75). The reaction mixture was then transferred to a round-bottomed flask and the volatile fraction distilled into a liquid-N2 trap by freeze-drying. A 0-1 ml. portion of the condensate was counted in methanol-Butyl-PBD in toluene (3: 8, v/v) (Ilml.) and the remaining solution divided into two parts.
The first halfwas tritrated with 0-1 M-NaOH, with phenolphthalein as indicator, to form the sodium salt offormic acid and test the recovery of formic acid, 100% recovery being equivalent to 7-8ml. of 0-1M-NaOH; all recoveries were between 97 and 102%. After titration the total volume was measured accurately and 6ml. of this solution was freezedried, and 0-1 ml. of the condensate was counted as before. To the residue of sodium formate 2 ml. of water was added and the solution was again freeze-dried to remove traces of tritiated water. The residue ofsodium formate was dissolved in 3ml. of water and a 0-1 ml. sample of the solution was counted.
The second portion of the acid-volatile distillate was analysed for formaldehyde by addition of40ml. ofdimedone reagent as described by Gabriel & Ashwell (1965) . The complex was allowed to form a precipitate for 1 hr. in the cold, the precipitate was filtered off, washed with water and crystallized twice from methanol-water. A 10-20mg. sample of the complex was weighed accurately and counted in 8 ml. of Butyl-PBD in toluene.
Preparation of 19-hydroxy-and 19-oxo-androst-5-ene compounds. (a) 19 -Hydroxyandrost-5 -en -33 -ol -17 -one 3 -acetate. 5a -Bromo -6/3,19 -epoxyandrostan -3,B -ol -17-one acetate (Akhtar & Barton, 1964) (1g.) was added to a suspension of zinc dust (6g.) in acetic acid-water (20: 1, v/v) (21 ml.) and the mixture was stirred at 200 for 1 hr. The zinc was filtered off, water was added and the solution extracted into methylene chloride or chloroform. The organic extract was washed sequentially with water and aqueous saturated NaHCO3 soln. and then dried over anhydrous Na2SO4. The product crystallized from methylene chloride-light petroleum (b.p. 60-800), m.p. 1556. 19-Hydroxyandrost-5-en-3/3-ol-17-one was prepared as follows. The 3-acetoxy compound (50mg.) in methanolic 5% (w/v) KOH (2 ml.) was heated to 500 and then left at room temperature for 2 hr. The solution was neutralized with 1 M-acetic acid, processed as above and crystallized from chloroform-diethyl etherlight petroleum (b.p. 60-800).
(b) 19-Hydroxyandrost-5-ene-3/3,17/3-diol 3,17-diacetate. This compound was prepared as above from 5ao-bromo-6/3,19-epoxyandrostan-3/3,17/3-diol diacetate (Kalvoda et al. *1963) -water (150ml.) , the precipitated steroid filtered off and the filtrate extracted with methylene chloride. The precipitate was added to the methylene chloride extract, and the solution was dried over Na2SO4, filtered and evaporated to an oil. The oil was dissolved in acetone (20ml.) and oxidized with a slight excess of Jones reagent (Bowden, Heilbron, Jones & Weedon, 1946) . Excess ofJones reagent was removed with methanol and the supernatant decanted from the precipitated chromous salts. The steroid crystallized on dropwise addition of water and cooling. The crystals of this compound, which decomposed at room temperature, were stored at -16°.
(b) 6/3,19-Epoxyandrost-4-ene-3,17-dione. 5a-Bromo-6/3,19-epoxyandrostane-3,17-dione (1g.) was refluxed with methanolic 5% (w/v) potassium acetate (lOOml.) for lhr. The solution was extracted with methylene chloride, processed as above and crystallized from diethyl etherlight petroleum (b.p. 60-800), m.p. 1810.
(c) 19-Hydroxyandrost-4-ene-3,17-dione (II). S5c-Bromo-6/3,19-epoxyandrostane-3,17-dione (l00mg.) or6p,19-epoxyandrost-4-ene-3,17-dione (100mg.) was added to a suspension of zinc dust (10g.) in acetic acid-water (20:1, v/v) (8-Oml.) and the mixture stirred under reflux for 8min.
